Clene Inc. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
Clene Inc. (CLNN) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of -$1.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2025-03-24
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-12-31 was $0.00.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-09-30 was $1.00K.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-06-30 was $2.00K, a 66.67% decline year-over-year.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-03-31 was -$4.00K, a 128.57% decline year-over-year.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2024 was -$1.00K, a 106.25% decline from fiscal 2023.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was $16.00K.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was -$14.00K.
- Clene Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2021 was $0.00.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.00K derived: sum of 2 quarters · filed 2025-03-24 | $3.00K derived: sum of 3 quarters · filed 2025-03-24 | -$1.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-13 | $3.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.00K 10-Q · filed 2024-11-13 | -$1.00K derived: sum of 4 quarters · filed 2025-03-24 |
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-07 | -$2.00K 10-Q · filed 2024-08-07 | -$2.00K derived: sum of 3 quarters · filed 2025-03-24 | -$6.00K derived: sum of 4 quarters · filed 2025-03-24 |
| 2024-03-31 | -$4.00K 10-Q · filed 2024-05-08 | -$4.00K derived: sum of 2 quarters · filed 2025-03-24 | -$8.00K derived: sum of 3 quarters · filed 2025-03-24 | -$2.00K derived: sum of 4 quarters · filed 2025-03-24 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$4.00K derived: sum of 2 quarters · filed 2025-03-24 | $2.00K derived: sum of 3 quarters · filed 2025-03-24 | $16.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$4.00K 10-Q · filed 2024-11-13 | $2.00K derived: sum of 2 quarters · filed 2024-11-13 | $16.00K 10-Q · filed 2024-11-13 | $56.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $6.00K 10-Q · filed 2024-08-07 | $20.00K 10-Q · filed 2024-08-07 | $60.00K derived: sum of 3 quarters · filed 2024-08-07 | $93.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-08 | $54.00K derived: sum of 2 quarters · filed 2024-05-08 | $87.00K derived: sum of 3 quarters · filed 2024-05-08 | $50.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $73.00K derived: sum of 2 quarters · filed 2024-03-13 | $36.00K derived: sum of 3 quarters · filed 2024-03-13 | -$14.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | $33.00K 10-Q · filed 2023-11-07 | -$4.00K derived: sum of 2 quarters · filed 2023-11-07 | -$54.00K 10-Q · filed 2023-11-07 | -$54.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$37.00K 10-Q · filed 2023-08-14 | -$87.00K 10-Q · filed 2023-08-14 | -$87.00K derived: sum of 3 quarters · filed 2023-08-14 | -$87.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$50.00K 10-Q · filed 2023-05-12 | -$50.00K derived: sum of 2 quarters · filed 2023-05-12 | -$50.00K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $0.00 10-K · filed 2023-03-13 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |